Latest market price
24.94
+0.23+0.93%
OverviewShort InterestFilings
NVSTQT46Envista Holdings Corp·NYSE
24.94+0.93%
TA
Loading chart...
Signal & projected range
Analyst consensus risingHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
ICUI-0.58%$161.44PLSE-1.23%$52.25MMSI+0.20%$84.48ATRC+1.85%$60.99STVN-26.49%$14.51TFX-1.44%$138.64BLCO+0.03%$20.02XRAY-1.48%$9.75
Snapshot
Index—P/E42.60EPS (ttm)0.58Insider Own1.80%Shs Outstand160.62MPerf Week4.44%
Market Cap3.97BForward P/E14.90EPS next Y1.66Insider Trans-0.28%Shs Float159.87MPerf Month5.33%
Enterprise Value4.43BPEG4.87EPS next Q0.36Short Float6.11%Perf Quarter-11.62%
Income96.00MP/S1.39EPS this Y33.57%Short Ratio3.52Perf Half Y-4.26%
Sales2.86BP/B1.29EPS next Y8.44%ROA1.70%Short Interest9.77MPerf YTD13.82%
Book/sh19.15P/C3.52EPS next 5Y8.74%ROE3.08%52W High30.42 -18.01%Perf Year22.69%
Cash/sh7.01P/FCF17.03EPS past 3/5Y-40.66% 1.49%ROIC2.38%52W Low18.77 32.87%Perf 3Y3.95%
Dividend Est.—EV/EBITDA10.86Sales past 3/5Y1.92% 7.11%Gross Margin55.50%Volatility3.58% 2.90%Perf 5Y-35.75%
Dividend TTM—EV/Sales1.55EPS Y/Y TTM84.42%Oper. Margin9.92%ATR (14)0.75Perf 10Y—
Dividend Ex-Date—Quick Ratio2.06Sales Y/Y TTM11.95%Profit Margin3.33%RSI (14)57.43Recom2.65
Dividend Gr. 3/5Y—Current Ratio2.43EPS Q/Q57.69%SMA205.83%Beta0.93Target Price28.60
Payout0.00%Debt/Eq0.52Sales Q/Q7.18%SMA500.67%Rel Volume1.39Prev Close24.71
Employees12,000LT Debt/Eq0.50EarningsNov 04SMA200-3.99%Avg Volume2.90MPrice24.94
IPO DateSep 18, 2019Option/ShortYes / YesEPS/Sales Surpr.22.30% 2.01%Net Debt/EBITDA1.13Volume4,038,110Change0.93%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-15-26ReiteratedRobert W. Baird$34 → $26
Oct-15-26DowngradeBairdOutperform → Neutral
Oct-14-26ReiteratedLeerink PartnersOutperform$35 → $32
Sep-28-26ReiteratedBMO CapitalMarket Perform$27 → $26
Sep-18-26ReiteratedUBSNeutral$25 → $27
Sep-03-26ReiteratedDeutsche Bank$32
Sep-03-26UpgradeJP MorganNeutral → Overweight
Aug-06-26ReiteratedMorgan StanleyEqual Weight$21 → $23
Aug-06-26ReiteratedRobert W. Baird$31 → $34
Aug-06-26ReiteratedMizuho SecuritiesNeutral$27 → $29
Latest News· Times ET
Oct-28-26
Oct-28-2611:31AM
Envista Q3 Earnings Ahead: Product Innovation to Drive Growthzacks.com
11:01AM
Envista (NVST) Earnings Expected to Grow: Should You Buy?zacks.com
Oct-27-26
Oct-27-2609:30PM
Envista Holdings Corporation Announces Publication of 2025 Sustainability ReportFintel
04:34PM
Envista Announces Release of 2025 Sustainability Reportprnewswire.com
Oct-26-26
Oct-26-2602:22PM
3 healthcare stocks we keep off our radarYahoo
Oct-18-26
Oct-18-2601:58AM
Reviewing MariMed (OTCMKTS:MRMD) and Envista (NYSE:NVST)defenseworld.net
Oct-15-26
Oct-15-2608:00AM
Every Tooth Deserves a Second Chance. Kerr Dental Introduces ZenFlex(TM) RT Rotary Retreatment File SystemYahoo
Oct-11-26
Oct-11-2602:59AM
Envista Holdings Corporation (NYSE:NVST) Stock Rated “Hold” by Wall Street Brokeragesdefenseworld.net
Oct-09-26
Oct-09-2610:41AM
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?zacks.com
Oct-08-26
Oct-08-2610:46AM
Here's Why Envista (NVST) is a Strong Growth Stockzacks.com
05:52AM
3 Cash-Producing Stocks We Find RiskyYahoo
Oct-07-26
Oct-07-2610:38AM
Recently Appointed Cooper Companies Director Paul Keel Buys $250,000 Stock. Does This Signal Shares are a Buy?fool.com
Oct-06-26
Oct-06-2604:15PM
Envista Schedules Third Quarter 2026 Earnings Callprnewswire.com
Oct-02-26
Oct-02-2607:42AM
1 of Wall Street’s Favorite Stocks to Keep an Eye On and 2 We IgnoreYahoo
Sep-28-26
Sep-28-2604:00AM
New Strong Buy Stocks for September 28thYahoo
Company

Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,8582,7202,5112,567—————
Cost of Goods Sold Incl. D&A1,2721,2231,1191,116—————
Gross Profit1,5851,4961,3921,451—————
Selling, General and Administrative Excl. Other1,1811,1571,1361,029—————
Research and Development1201149994—————
Other Operating Expense101,195296—————
Operating Income284226-1,03832—————
Interest Expense21374663—————
Unusual Expense
—————————
Non-Operating Income (Expense)-29-120-23—————
Net Income Before Taxes234177-1,085-55—————
Income Taxes1401303445—————
Consolidated Net Income9647-1,119-100—————
Net Income From Continuing Operations9647-1,119-100—————
Net Income9647-1,119-100—————
EPS (Recurring)0.590.28-6.50-0.60—————
EPS (Basic, Before Extraordinaries)0.590.28-6.50-0.60—————
EPS (Diluted)0.580.28-6.50-0.60—————
EBITDA408330280490—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio43.0077.54———————
Price To Sales Ratio1.411.341.321.57—————
Gross Margin55.4655.0055.4456.53—————
Operating Margin9.948.31-41.341.25—————
Net Margin3.361.73-44.56-3.90—————
Shares Outstanding162168172167—————
Market Capitalization4,0403,6473,3184,018—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$31.96$28.28$24.61$20.93$17.25● Close Price0.00K55.00K110.00K165.00K220.00KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Reis MischaSVP, Strategy & Bus. Dev.Aug 20 '26Sale27.508,000220,00027,321Aug 24
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Option Exercise17.259,675166,91638,016Feb 11
Reis MischaSVP, Strategy & Bus. Dev.Feb 10 '26Sale30.005,634169,02032,382Feb 11
Reis MischaSVP, Strategy & Bus. Dev.Aug 25 '25Sale21.6015,000324,00032,382Aug 27
Keel Paul AChief Executive OfficerAug 13 '24Buy16.8730,000506,100402,605Aug 14
Hammes Eric D.Chief Financial OfficerAug 12 '24Buy16.3324,532400,60824,532Aug 13
Conley EricSVP, OrthodonticsNov 16 '23Buy22.892,18550,01547,376Nov 20
Nance Mark EGeneral CounselNov 08 '23Buy21.755,000108,75039,042Nov 09
Aghdaei AmirChief Executive OfficerNov 06 '23Buy21.5310,000215,254295,362Nov 07
Keller StephenPrincipal Financial OfficerNov 06 '23Buy21.532,00043,06013,070Nov 07
Yu Howard HChief Financial OfficerFeb 28 '23Sale37.9010,016379,60645,865Mar 01
Yu Howard HChief Financial OfficerNov 17 '22Sale36.5565724,01351,106Nov 21
Yu Howard HChief Financial OfficerApr 18 '22Sale45.735,341244,24452,411Apr 20
Aghdaei AmirChief Executive OfficerMar 29 '22Sale51.503,801195,752364,779Mar 31
Yu Howard HChief Financial OfficerMar 21 '22Option Exercise21.764,786104,14459,682Mar 22
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.